跳至主要内容
临床试验/CTRI/2025/07/090093
CTRI/2025/07/090093尚未招募2/3 期

A randomized controlled clinical trial to evaluate the efficacy of langali ksharasutra in the management of bhagandara.

Dr Hafis Muhammed KM1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年7月14日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Effect of treatment will be assessed on the basis

研究概览

简要总结

RANDOMIZED CONTROLLED CLINICAL TRIAL :- Evaluating the efficacy of langali ksharasutra in Management of Bhagandara using two study groups .In Group A (Standard group) Apamarga ksharasutra will be used and in  group B (Trial group) Langali ksharasutra is used for ligation of tracts. Total study period including follow up will be upto 90 days, (where ksharasutra is changed each week up to 60 days or till tract cut off. It will be followed by follow up once in every week for one month).Outcome assessed through subjective and objective parameters.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant Blinded

入排标准

年龄范围
16.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.The patients having classical symptoms of Bhagandara will be selected.
  • 2.Patients will be selected between the age group of 16 -70 yrs.
  • of either gender, irrespective of religion, occupation, economic status.

排除标准

  • 1.Patients suffering secondary to inflammatory diseases like Ulcerative colitis and Crohn’s disease.
  • 2.Fistula in ano associated with Multiple tracts, Fissure in Ano, Hemarrhoids, Anal stricture, Malignancy and Polyps.
  • 3.Patients suffering from HIV, Tuberculosis, CA of rectum and Hepatitis B.
  • 4.Pregnant women.

结局指标

主要结局

Effect of treatment will be assessed on the basis

时间窗: Follow up once every week for one month after study period

of gradation of both subjective and objective

时间窗: Follow up once every week for one month after study period

parameters before and after treatment.

时间窗: Follow up once every week for one month after study period

次要结局

  • Length of tract (in cm)

研究者

发起方
Dr Hafis Muhammed KM
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Hafis Muhammed KM

Alvas Ayurveda Medical College

研究点 (1)

Loading locations...

相似试验